Nanotechnology antimicrobial spray for abscess treatment

A randomized controlled trial of comparing nanotechnology antimicrobial spray versus traditional wound dressing in the treatment of small abscesses in the Accident and Emergency Department - A randomized controlled trial of comparing nanotechnology antimicrobial spray versus traditional wound dressing in the treatment of small abscesses in the Accident and Emergency Department

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053526

Enrollment

Registered

2024-02-03

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of small abscesses in the Accident and Emergency Department

Interventions

Applying traditional wound dressing to wound after incision and drainage of abscess Applying nanotechnology spray to wound after incision and drainage of abscess at day 3

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Abscesses of sizes 3 cm and below requiring incision and drainage presenting to the Emergency Department

Exclusion criteria

Exclusion criteria: - Diabetes mellitus - Peripheral vascular disease - On oral steroids or other immunosuppressant drug - Pregnancy - Tourists - Language barriers - Mentally incapacitated - Abscesses located on the face - Abscesses located on the perineum

Design outcomes

Primary

Measure	Time frame
- Healing time after incision and drainage	—

Secondary

Measure	Time frame
- Pain, on a 10 point Likert-type scales at last follow up - Patient satisfaction, on a 10 point Likert-type scales at last follow up	—

Countries

Asia(except Japan)

Contacts

Public ContactSiu Kei Sam Hon

Hong Kong Hospital Authority, Ruttonjee Hospital Accident and Emergency Department

skhon1@gmail.com+85222912012

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026